US FDA joins global regulators probing tainted overseas cough syrup, Health News, ET HealthWorld

New York: The US Food and Drug Administration said on Wednesday it is working with the World Health Organisation and foreign regulatory authorities to support an investigation into the source of contaminated cough syrups that have killed more than 300 children in Africa and Asia. In a statement, the FDA said it had no indication that contaminated syrups had entered the US drug supply chain, but it is “investigating the potential impact and scope of this hazard on FDA-regulated products.” The agency recommended consumers only take medicines which were made…

Read More

WHO urges ‘immediate action’ after cough syrup deaths, Health News, ET HealthWorld

London: The World Health Organization has called for “immediate and concerted action” to protect children from contaminated medicines after a spate of child deaths linked to cough syrups last year. In 2022, more than 300 children mainly aged under 5 – in Gambia, Indonesia and Uzbekistan died of acute kidney injury, in deaths that were associated with contaminated medicines, the WHO said in a statement on Monday. The medicines, over-the-counter cough syrups, had high levels of diethylene glycol and ethylene glycol. “These contaminants are toxic chemicals used as industrial solvents…

Read More

Cough Syrups: The inaction of Indian drug regulators on cough syrup deaths, Health News, ET HealthWorld

By Prabhat Prakash and Abhishek Bhatia New Delhi: Indian-made cough syrups have been grabbing the limelight for all the wrong reasons. Recently children’s deaths were reported from the Gambia where approximately 70 children died due to acute kidney injury, which was attributed to the consumption of cough syrups imported from India. 18 children deaths have been reported in Uzbekistan after consuming the India-made cough syrups. As per the WHO’s findings, the cough syrups were found to be contaminated with de-ethylene glycol (DEG) and ethylene glycol (EG), chemicals commonly used for…

Read More

Centre appoints four-member committee to examine Gambia cough syrup-related deaths – ET HealthWorld

New Delhi: Maiden Pharmaceuticals has been at the centre of a controversy after the deaths of 66 children in Gambia were linked to the consumption of cough syrups manufactured and exported by the company. The Union Health Ministry has appointed a four-member committee for further investigation. The committee will, after examining and analysing adverse event reports, causal relationships and all related details shared by WHO, suitably advise and recommend Drug Controller General of India (DCGI) about the further course of action. The committee may co-opt any other technical expert as…

Read More

Codeine cough syrup rules may get tighter – ET HealthWorld

Ahmedabad: The central government could introduce new guidelines to monitor the supply and distribution of codeine-based cough syrups (CBCSs). The government was considering banning CBCSs, but the pharma industry asked for stricter guidelines to monitor their supply instead. As of now, manufacturers have quota manufacture of codeine cough syrups, but the government could introduce rules for distributors and retailers to ensure these syrups do not reach unofficial outlets such as paan shops. An office-bearer of the Indian Drug Manufacturers’ Association (IDMA), on condition of anonymity, said, “We have requested the…

Read More

WHO alert on cough syrups ‘alarming’, there are missing links that need to be probed: Expert – ET HealthWorld

The WHO‘s recent alert linking cough syrups manufactured by an Indian pharmaceutical firm to the deaths of children in Gambia is “alarming” and there are some missing links that need to be “investigated”, an expert said on Saturday. The World Health Organisation on Wednesday issued an alert, saying four “contaminated” and “substandard” cough syrups produced by Maiden Pharmaceuticals Limited could be the reason for the deaths in the West African nation. The four products are Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold…

Read More

CDSCO takes up urgent investigation on WHO’s complaint for India-made cough syrups – ET HealthWorld

New Delhi: After the World Health Organization (WHO) issued an alert on four India-made cough and cold syrups used for paediatric groups, the Central Drugs Standard Control Organisation (CDSCO) has taken up an urgent investigation in this regard. “Urgent investigation in the matter has been already taken up by CDSCO with the State Regulatory Authorities immediately after receiving communication from WHO based on the available information. While all required steps will be taken in the matter, as a robust National Regulatory Authority, WHO has been requested to share at the…

Read More

India-made cough syrups may be tied to 66 deaths in Gambia: WHO – ET HealthWorld

The World Health Organization on Wednesday said that four cough and cold syrups made by India’s Maiden Pharmaceuticals Ltd could be potentially linked with serious kidney injuries and 66 deaths among children in Gambia. New Delhi-based Maiden Pharmaceuticals declined to comment on the matter. WHO issued a medical product alert for the four syrups and said it was conducting further investigation with the company and regulatory authorities in India. Gambia’s government said last month it has also been investigating the deaths, as a spike in cases of acute kidney injury…

Read More